Release Date: 31/05/19 17:54 Summary: Response to ASX Price Query Price Sensitive: Yes Download Document 229.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%